TPST
Tempest Therapeutics Inc.
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||||||
| Capital Expenditures | 0 | 435,000 | 170,000 | 562,000 | 135,000 | 50,000 | 397,000 | 36,000 | 4,000 | 2.6M | 5.2M | 2.8M | 719,000 |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||||||
| Free Cash Flow | -26.8M | -33.5M | -27.5M | -31.6M | -26.1M | -19.1M | -41.6M | -23.7M | -20.3M | -64.3M | -55.5M | -33.4M | -18.8M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — | — | — |